Stifel's Head of Therapeutics Research Paul Matteis shares his take on the sector and discusses names he covers that have key catalyst events
- blonca9
- 9 hours ago
- 1 min read
He shares his thoughts on uniQure, Xenon, Alkermes, Compass Pathways, GH Research MindMed, and Dyne.
Coverage brought to you by












.png)




